Description

Yabao Compound Troxerutin & Coumarin Tablets deliver a standardized blend of troxerutin (a hydroxyethylrutin derivative) and coumarin. Troxerutin supports capillary resistance and microcirculatory health, while coumarin adds anti-inflammatory and mild anticoagulant effects. Together, they are used in research models exploring venous insufficiency, edema reduction, microvascular health, and inflammatory responses.

Formulated and manufactured by Yabao Pharmaceutical Group Co., Ltd., under NMPA approval H14023273 and assigned barcode 6916107517492.

?? For research use only. Not approved for therapeutic or diagnostic use in humans or animals.

Product Specifications

Mechanism of Action

• Troxerutin strengthens capillary walls, reduces permeability, improves microcirculation, and combats oxidative stress in vessel endothelial cells.

• Coumarin exhibits mild anti-inflammatory, anticoagulant, and choleretic effects via modulation of prostaglandin and hyaluronic acid pathways .

Research Applications

• Microcirculation and capillary fragility studies

• Venous insufficiency and edema models

• Antioxidant/inflammatory assays

• Hepatobiliary and choleretic pathway research

• Soft tissue injury and vascular permeability models

Safety & Handling

• For research use only

• Use PPE: gloves, goggles, lab coat

• Avoid ingestion, inhalation, and skin contact

• Store sealed, away from light

• Refer to COA and SDS for detailed safety and purity data

Core Keywords

Compound Troxerutin & Coumarin Tablets, Troxerutin CAS 7085-55-4, Coumarin CAS 91-64-5, vascular research tablets, Yabao troxerutin tablets, microcirculation study compound, anti-inflammatory flavonoid tablets, non-prescription lab tablets

Research Use Disclaimer

This product is intended strictly for scientific research purposes. It is not approved for therapeutic, diagnostic, or veterinary use. Misuse may pose health or legal risks. Use only under proper lab protocols.